Further investigations are needed to verify whether these new compounds induce similar changes in the molecular profiles of melanoma cells as D6 does to confirm that their mechanism of action involves the modulation of p53 signaling and cell cycle regulators, as suggested by their behavior. This evidence concerns the gene TP53 and melanoma.